1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
5	virus	virus	_	_	_	_	_	_	_
6	type	type	_	_	_	_	_	_	_
7	1	1	_	_	_	_	_	_	_
8	replication	replication	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	Tat-activated	tat-activated	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	transduced	transduce	_	_	_	_	_	_	_
14	interferon	interferon	_	_	_	_	_	_	_
15	gene	gene	_	_	_	_	_	_	_
16	:	:	_	_	_	_	_	_	_
17	targeted	target	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
22	virus	virus	_	_	_	_	_	_	_
23	type	type	_	_	_	_	_	_	_
24	1-infected	1-infected	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	feasibility	feasibility	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	using	use	_	_	_	_	_	_	_
8	interferon	interferon	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	IFN	IFN	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	transfer	transfer	_	_	_	_	_	_	_
14	as	as	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	novel	novel	_	_	_	_	_	_	_
17	approach	approach	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	anti-human	anti-human	_	_	_	_	_	_	_
20	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
21	virus	virus	_	_	_	_	_	_	_
22	type	type	_	_	_	_	_	_	_
23	1	1	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	HIV-1	HIV-1	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	therapy	therapy	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	this	this	_	_	_	_	_	_	_
30	study	study	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	limit	limit	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	transduced	transduce	_	_	_	_	_	_	_
7	HIV-1	HIV-1	_	_	_	_	_	_	_
8	long	long	_	_	_	_	_	_	_
9	terminal	terminal	_	_	_	_	_	_	_
10	repeat	repeat	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	LTR)-IFNA2	LTR)-IFNA2	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	new	new	_	_	_	_	_	_	_
16	approved	approve	_	_	_	_	_	_	_
17	nomenclature	nomenclature	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	IFN	IFN	_	_	_	_	_	_	_
20	genes	gene	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	used	use	_	_	_	_	_	_	_
23	throughout	throughout	_	_	_	_	_	_	_
24	this	this	_	_	_	_	_	_	_
25	article	article	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	hybrid	hybrid	_	_	_	_	_	_	_
28	gene	gene	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
32	cells	cell	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	HIV-1	HIV-1	_	_	_	_	_	_	_
35	LTR	LTR	_	_	_	_	_	_	_
36	was	be	_	_	_	_	_	_	_
37	modified	modify	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Deletion	deletion	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	elements	element	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	HIV-1	HIV-1	_	_	_	_	_	_	_
10	LTR	LTR	_	_	_	_	_	_	_
11	significantly	significantly	_	_	_	_	_	_	_
12	inhibited	inhibit	_	_	_	_	_	_	_
13	Tat-mediated	tat-mediated	_	_	_	_	_	_	_
14	transactivation	transactivation	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	T-cell	t-cell	_	_	_	_	_	_	_
17	lines	line	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	as	as	_	_	_	_	_	_	_
20	well	well	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	monocyte	monocyte	_	_	_	_	_	_	_
25	line	line	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	U937	U937	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Replacement	replacement	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	elements	element	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	HIV-1	HIV-1	_	_	_	_	_	_	_
10	LTR	LTR	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	DNA	DNA	_	_	_	_	_	_	_
14	fragment	fragment	_	_	_	_	_	_	_
15	derived	derive	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	5â€™-flanking	5'-flanking	_	_	_	_	_	_	_
19	region	region	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	IFN-stimulated	ifn-stimulated	_	_	_	_	_	_	_
22	gene	gene	_	_	_	_	_	_	_
23	15	15	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	ISG15	ISG15	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	containing	contain	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	IFN-stimulated	ifn-stimulated	_	_	_	_	_	_	_
31	response	response	_	_	_	_	_	_	_
32	element	element	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	partially	partially	_	_	_	_	_	_	_
35	restored	restore	_	_	_	_	_	_	_
36	Tat-mediated	tat-mediated	_	_	_	_	_	_	_
37	activation	activation	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	LTR	LTR	_	_	_	_	_	_	_
40	in	in	_	_	_	_	_	_	_
41	T	t	_	_	_	_	_	_	_
42	cells	cell	_	_	_	_	_	_	_
43	as	as	_	_	_	_	_	_	_
44	well	well	_	_	_	_	_	_	_
45	as	as	_	_	_	_	_	_	_
46	in	in	_	_	_	_	_	_	_
47	monocytes	monocyte	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	Insertion	Insertion	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	chimeric	chimeric	_	_	_	_	_	_	_
5	promoter	promoter	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	ISG15	ISG15	_	_	_	_	_	_	_
8	LTR	LTR	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	upstream	upstream	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	IFNA2	ifna2	_	_	_	_	_	_	_
15	gene	gene	_	_	_	_	_	_	_
16	directed	direct	_	_	_	_	_	_	_
17	high	high	_	_	_	_	_	_	_
18	levels	level	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	IFN	ifn	_	_	_	_	_	_	_
21	synthesis	synthesis	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	Tat-expressing	tat-expressing	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	while	while	_	_	_	_	_	_	_
27	this	this	_	_	_	_	_	_	_
28	promoter	promoter	_	_	_	_	_	_	_
29	was	be	_	_	_	_	_	_	_
30	not	not	_	_	_	_	_	_	_
31	responsive	responsive	_	_	_	_	_	_	_
32	to	to	_	_	_	_	_	_	_
33	tumor	tumor	_	_	_	_	_	_	_
34	necrosis	necrosis	_	_	_	_	_	_	_
35	factor	factor	_	_	_	_	_	_	_
36	alpha-mediated	alpha-mediated	_	_	_	_	_	_	_
37	activation	activation	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	ISG15-LTR-IFN	isg15-ltr-ifn	_	_	_	_	_	_	_
2	hybrid	hybrid	_	_	_	_	_	_	_
3	gene	gene	_	_	_	_	_	_	_
4	inserted	insert	_	_	_	_	_	_	_
5	into	into	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	retrovirus	retrovirus	_	_	_	_	_	_	_
8	vector	vector	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	transduced	transduce	_	_	_	_	_	_	_
11	into	into	_	_	_	_	_	_	_
12	Jurkat	Jurkat	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	U937	u937	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Selected	select	_	_	_	_	_	_	_
2	transfected	transfecte	_	_	_	_	_	_	_
3	clones	clone	_	_	_	_	_	_	_
4	produced	produce	_	_	_	_	_	_	_
5	low	low	_	_	_	_	_	_	_
6	levels	level	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	IFN	IFN	_	_	_	_	_	_	_
9	A	A	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	IFNA	IFNA	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	constitutively	constitutively	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	their	their	_	_	_	_	_	_	_
17	abilities	ability	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	express	express	_	_	_	_	_	_	_
20	interleukin-2	interleukin-2	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	interleukin-2	interleukin-2	_	_	_	_	_	_	_
23	receptor	receptor	_	_	_	_	_	_	_
24	upon	upon	_	_	_	_	_	_	_
25	stimulation	stimulation	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	phytohemagglutinin	phytohemagglutinin	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	phorbol	phorbol	_	_	_	_	_	_	_
30	myristate	myristate	_	_	_	_	_	_	_
31	acetate	acetate	_	_	_	_	_	_	_
32	were	be	_	_	_	_	_	_	_
33	retained	retain	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Enhancement	enhancement	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	IFNA	IFNA	_	_	_	_	_	_	_
4	synthesis	synthesis	_	_	_	_	_	_	_
5	observed	observe	_	_	_	_	_	_	_
6	upon	upon	_	_	_	_	_	_	_
7	HIV-1	HIV-1	_	_	_	_	_	_	_
8	infection	infection	_	_	_	_	_	_	_
9	resulted	result	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	significant	significant	_	_	_	_	_	_	_
12	inhibition	inhibition	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	HIV-1	HIV-1	_	_	_	_	_	_	_
15	replication	replication	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	period	period	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	at	at	_	_	_	_	_	_	_
21	least	least	_	_	_	_	_	_	_
22	30	30	_	_	_	_	_	_	_
23	days	day	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Virus	virus	_	_	_	_	_	_	_
2	isolated	isolate	_	_	_	_	_	_	_
3	from	from	_	_	_	_	_	_	_
4	IFNA-producing	ifna-producing	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	able	able	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	replicate	replicate	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	U937	u937	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	but	but	_	_	_	_	_	_	_
15	did	do	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	replicate	replicate	_	_	_	_	_	_	_
18	efficiently	efficiently	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	U937	u937	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	transduced	transduce	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	IFNA	IFNA	_	_	_	_	_	_	_
26	gene	gene	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	targeting	target	_	_	_	_	_	_	_
6	IFN	ifn	_	_	_	_	_	_	_
7	synthesis	synthesis	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	an	an	_	_	_	_	_	_	_
13	attainable	attainable	_	_	_	_	_	_	_
14	goal	goal	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	autocrine	autocrine	_	_	_	_	_	_	_
18	IFN	IFN	_	_	_	_	_	_	_
19	synthesis	synthesis	_	_	_	_	_	_	_
20	results	result	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	long-lasting	long-lasting	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	permanent	permanent	_	_	_	_	_	_	_
26	suppression	suppression	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	HIV-1	HIV-1	_	_	_	_	_	_	_
29	replication	replication	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

